Header image

COVID-19 immunology

Friday, July 28, 2023
10:30 AM - 12:00 PM
Ballroom 1


Agenda Item Image
A/Prof Amy Chung
Laboratory Head
Uni Melbourne, Doherty Institute

Robust immune responses towards COVID-19 vaccine in First Nations peoples are impacted by comorbidities

10:30 AM - 10:45 AM

presentation recording


Dr Amy Chung is a Laboratory Head at the Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute. Her research focuses upon the application of cutting-edge experimental technologies to holistically examine functional antibodies against a range of infectious diseases including HIV. This research can be used to design future antibody-based vaccines and can contribute to the generation of improved monoclonal antibody therapeutics.
Agenda Item Image
Prof. David Lynn
Prof. of Systems Immunology
SAHMRI and Flinders University

A systems immunology study comparing innate and adaptive immune responses to COVID-19 mRNA and adenovirus-vectored vaccines

10:45 AM - 11:00 AM


Prof. David Lynn is Head of the Systems Immunology Laboratory at SAHMRI; Scientific Director of SA Genomics Centre; and Professor at Flinders University. His research investigates how microbes (pathogenic and commensal) modulate the immune system in a range of contexts from infection (including COVID-19) to immunisation and immunotherapy.
Agenda Item Image
Dr Hyon-Xhi Tan
Post-doctoral Fellow
Peter Doherty Institute, University of Melbourne

Intranasal delivery of nanoparticulate SARS-CoV-2 vaccines using recombinant influenza vectors to elicit enhanced mucosal humoral responses

11:00 AM - 11:15 AM


Hyon-Xhi Tan is an NHMRC Fellow at the Viral Vax Lab (viralvaxlab.com), Doherty Institute, focusing on anti-viral humoral immunity against influenza and human coronaviruses. His research has detailed mechanisms driving B cell recognition of viral antigens, developed novel vaccine strategies to enhance neutralising antibodies and established insights underpinning lung immunity.
Agenda Item Image
Dr Mee Ling Munier
Research Fellow
The Kirby Institute, Unsw Sydney

To switch or not to switch - an approach for rapid vaccine coverage

11:15 AM - 11:30 AM


Mee Ling Munier is a Research Fellow at the Kirby Institute, UNSW Sydney. Her group utilises fine needle biopsies (FNB) / fine needle aspirates (FNA) to study immune responses to vaccination within human lymph nodes. To characterise the cellular responses, high dimensional flowcytometry and single cell RNA-sequencing methods are employed.
Agenda Item Image
Associate Professor Corey Smith
Group Leader
QIMR Berghofer Medical Research Institute

SARS-CoV-2 T cell immunity in South East QLD

11:30 AM - 11:45 PM

presentation recording


Associate Professor Smith heads the Translational and Human Immunology laboratory at QIMR Berghofer Medical Research Institute. His work focuses upon T-cell mediated control of infection and cancer and the application of this knowledge to develop T cell immunotherapies. His work has been translated into multiple clinical trials in head and neck cancer, brain cancer, organ transplant recipients, multiple sclerosis and COVID-19.

Chair Person

Agenda Item Image
Jerome Kim
Director General
International Vaccine Institute, Korea

Wen Shi Lee
Postdoctoral Researcher
Peter Doherty Institute, University Of Melbourne